Hims & Hers Health, Inc.
Hims & Hers Health Reports Strong Q2 2025 Financial Results
Summary
Hims & Hers Health, Inc. reported significant financial growth for the second quarter of 2025, with revenue increasing by 73% year-over-year to $544.8 million, and net income rising to $42.5 million. The company also experienced a 31% increase in subscribers, reaching over 2.4 million. Adjusted EBITDA more than doubled to $82.2 million. The company affirmed its full-year 2025 revenue guidance of $2.3 billion to $2.4 billion and Adjusted EBITDA guidance of $295 million to $335 million. The full financial results are detailed in the press release furnished as Exhibit 99.1.
Profitelligence Alerts
Get alerts for HIMS
Be first to know when Hims & Hers Health, Inc. files with the SEC.
Filing Categories
Exhibits (2)
Advertisement
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. is a telehealth service provider that aims to simplify and enhance healthcare access for consumers. The company specializes in personal care and wellness products and services, offering both prescription and over-the-counter solutions. With a focus on destigmatizing health and wellness issues, Hims & Hers addresses areas such as dermatology, sexual health, hair care, and mental wellness, appealing to a broad demographic looking for convenient and private healthcare options. By facilitating online consultations with licensed medical professionals, the company allows users to receive medical advice, treatments, and prescriptions, all accessible from the comfort of their homes. Hims & Hers plays a significant role in the growing digital healthcare market, leveraging technology to provide more accessible and personalized healthcare experiences. Headquartered in San Francisco, the company capitalizes on the increase in demand for telehealth services, buoyed by advancements in digital health trends and the expanding e-commerce space for healthcare solutions.
Official SEC Documents
Advertisement